NCT01332097 - Safety & Efficacy of BCT197A2201 in COPD Patients Presenting With an Exacerbation | Biotech Hunter

Enrollment

183

Participants

Timeline

Start Date

March 31, 2011

Primary Completion Date

May 31, 2013

Study Completion Date

May 31, 2013

Conditions

Chronic Obstructive Pulmonary Disease

Interventions

DRUG

BCT197

DRUG

Prednisone placebo

capsules

DRUG

BCT197 placebo

capsules

DRUG

Prednisone

capsules

Trial Locations (6)

Novartis Investigative Site, Plovdiv

Novartis Investigative Site, Rousse

Novartis Investigative Site, Bucharest

Novartis Investigative Site, Moscow

Novartis Investigative Site, Moscow

Novartis Investigative Site, Saint Petersburg